Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand

Background:
The World Health Organization (WHO) has developed the Total System Effectiveness (TSE) framework to assist national policy-makers in prioritizing vaccines. The pilot was launched in Thailand to explore the potential use of TSE in a country with established governance structures and accountable decision-making processes for immunization policy. While the existing literature informs vaccine adoption decisions in GAVI-eligible countries, this study attempts to address a gap in the literature by examining the policy process of a non-GAVI eligible country.

Methods:
A rotavirus vaccine (RVV) test case was used to compare the decision criteria made by the existing processes (Expanded Program on Immunization [EPI], and National List of Essential Medicines [NLEM]) for vaccine prioritization and the TSE-pilot model, using Thailand specific data.

Results:
The existing decision-making processes in Thailand and TSE were found to offer similar recommendations on the selection of a RVV product.

Conclusion:
The authors believe that TSE can provide a well-reasoned and step by step approach for countries, especially low- and middle-income countries (LMICs), to develop a systematic and transparent decision-making process for immunization policy.

Read the full article.

You May Also Like

Linked Country Case Study: Strengthening Tunisia’s HPV Vaccine Introduction

The Linked Immunisation Action Network played a pivotal role in supporting Tunisia’s HPV vaccine introduction by leveraging peer-to-peer learning and cross-regional collaboration. Tunisia joined the network in 2023 during critical preparations for its school-based HPV rollout targeting 12-year-old girls. Participation in global workshops, including an Istanbul session with peers like the Philippines and Mongolia, provided … Read More

Download
File size: 2.56M

Health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination program in adolescents in LMICs: An analysis of Indonesia

A study in PLOS ONE evaluates the feasibility and impact of a single-dose 9-valent HPV vaccination program in Indonesia, focusing on its potential to reduce cervical cancer rates. The research highlights that a single-dose regimen is cost-effective, logistically simpler, and more accessible, particularly in low-resource settings. It also emphasizes the importance of community engagement and … Read More

HPV introduction and implementation: Case studies from Africa and South Asia

This special issue of Vaccine focuses on innovations and challenges in strengthening immunization programs globally. Key themes include the integration of new vaccine technologies, such as mRNA vaccines, into existing systems, and strategies to address inequities in vaccine access. Several articles highlight the importance of data-driven decision-making, supply chain resilience, and workforce training to improve … Read More